US Patent Issued to MJCELL BIO on June 17 for "Human anti-ANTXR chimeric antigen receptor and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,087, issued on June 17, was assigned to MJCELL BIO Co. LTD. (Gyeonggi-Do, South Korea).

"Human anti-ANTXR chimeric antigen receptor and use thereof" was invented by Kyung-Mi Lee (Seoul, South Korea), Seung-Hyun Jeon (Seoul, South Korea), Baeckseung Lee (Seoul, South Korea), Yoon Lee (Gyeonggi-do, South Korea) and Young-Kwan Lee (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a chimeric antigen receptor having a ligand specifically targeting an anthrax toxin receptor (ANTXR), and, more specifically, to: a nucleic acid encoding a chimeric antigen receptor comprising ligand PA63 specifically binding t...